- Pfizer (New York, NY)
- …the development strategy for programs within the Late - Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for assigned ... studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and… more
- Pfizer (New York, NY)
- …from Research to Proof of Concept at which point molecule may be handed to the late - stage Oncology Clinical Development team for post-Proof of Concept ... plan, and regulatory documents. + Provide leadership to early stage clinical scientists on the clinical...Regulatory Strategy, Clinical Pharmacology and Precision Medicine, Oncology Clinical Development and Operations, Pharm Sci… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …and execution of clinical research and development studies for early and/or late stage assets; Assists with development of the Expanded Synopsis and may ... may contribute to candidate development projects through early and/or late phase development. The Senior Manager reports to the... studies and programs. As a Senior Manager in Oncology Clinical Sciences, **a typical day may… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …Experience in conducting global clinical trials in both early- and late - stage clinical development, especially protocol development and trial initiation ... study concept to clinical study protocol for both early- and late - stage programs + Leads or joins multi-disciplinary, multi-regional, matrix team through… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... and experienced individual for the position of **Medical Director, Clinical Development - Oncology ** . The medical...relevant affiliates. + Work in close collaboration with the late - stage development group. + Perform other duties… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... a primary focus on advancing translational research to support oncology programs in clinical trial stages. This...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …implementation of clinical biomarker strategies across key programs in early and late stage drug development. Further, this role is responsible for providing ... in pharmaceutical or biotech industry, including a minimum of **5 years in oncology clinical drug development is required** . Does this sound like you? Apply now… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (New York, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Albany, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Albany, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Brooklyn, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Mitsubishi Chemical Group (New York, NY)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more